Home Carboxes 62603-54-7
62603-54-7,MFCD00140798
Catalog No.:AA00ER87

62603-54-7 | 4-Chloro[1,2,4]triazolo[4,3-a]quinoxaline

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
1 week  
$124.00   $87.00
- +
250mg
95%
1 week  
$211.00   $148.00
- +
1g
95%
1 week  
$546.00   $382.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00ER87
Chemical Name:
4-Chloro[1,2,4]triazolo[4,3-a]quinoxaline
CAS Number:
62603-54-7
Molecular Formula:
C9H5ClN4
Molecular Weight:
204.6158
MDL Number:
MFCD00140798
SMILES:
Clc1nc2ccccc2n2c1nnc2
Properties
Properties
 
Form:
Solid  

Computed Properties
 
Complexity:
225  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
3  
XLogP3:
2.5  

Downstream Synthesis Route

[1]Sarges,Reinhard;Howard,HarryR.;Browne,RonaldG.;Lebel,LorraineA.;Seymour,PatriciaA.;Koe,B.Kenneth[JournalofMedicinalChemistry,1990,vol.33,#8,p.2240-2254]

[2]El-Adl,Khaled;El-Helby,Abdel-GhanyA.;Sakr,Helmy;Elwan,Alaa[NewJournalofChemistry,2021,vol.45,#2,p.881-897]

[3]Lee,Sujin;Cil,Onur;Diez-Cecilia,Elena;Anderson,MarcO.;Verkman,AlanS.[JournalofMedicinalChemistry,2018,vol.61,#7,p.3209-3217]

[4]Locationinpatent:experimentalpartSoliman;Amer[SyntheticCommunications,2012,vol.42,#10,p.1401-1410]

[5]Trivedi;Bruns[JournalofMedicinalChemistry,1988,vol.31,#5,p.1011-1014]

[6]CurrentPatentAssignee:ELILILLY&CO-US4008322,1977,A

[7]Ali,Imran;Lee,Jooyun;Go,Areum;Choi,Gildon;Lee,Kwangho[BioorganicandMedicinalChemistryLetters,2017,vol.27,#20,p.4606-4613]

[8]Ibrahim;Taghour;Metwaly;Belal;Mehany;Elhendawy;Radwan;Yassin;El-Deeb;Hafez;ElSohly;Eissa[EuropeanJournalofMedicinalChemistry,2018,vol.155,p.117-134]

[9]Eissa,IbrahimH.;Metwaly,AhmedM.;Belal,Amany;Mehany,AhmedB.M.;Ayyad,RezkR.;El-Adl,Khaled;Mahdy,HazemA.;Taghour,MohammedS.;El-Gamal,KamalM.A.;El-Sawah,MohamadE.;Elmetwally,SouadA.;Elhendawy,Mostafa.A.;Radwan,MohamedM.;ElSohly,MahmoudA.[ArchivderPharmazie,2019,vol.352,#11]

[10]ElSaeed,HodaS.;Bayoumi,AshrafH.;Sarg,MarwaT.;Ghiaty,AdelH.[JournalofHeterocyclicChemistry,2020,vol.57,#12,p.4358-4372]

[11]El-Adl,Khaled;El-Helby,Abdel-GhanyA.;Sakr,Helmy;Elwan,Alaa[BioorganicChemistry,2020,vol.105]Abdelgawad,MohamedA.;El-Adl,Khaled;El-Helby,Abdel-GhanyA.;El-Sherbiny,Mohamed;El-morsy,Ahmed;Elwan,Alaa;Ghoneim,MohammedM.;Sakr,Helmy[JournalofEnzymeInhibitionandMedicinalChemistry,2022,vol.37,#1,p.1556-1567]

[12]Alsaif,NawafA.;Dahab,MohammedA.;Alanazi,MohammedM.;Obaidullah,AhmadJ.;Al-Mehizia,AbdulrahmanA.;Alanazi,ManalM.;Aldawas,Saleh;Mahdy,HazemA.;Elkady,Hazem[BioorganicChemistry,2021,vol.110]Alsaif,NawafA.;Taghour,MohammedS.;Alanazi,MohammedM.;Obaidullah,AhmadJ.;Alanazi,WaelA.;Alasmari,Abdullah;Albassam,Hussam;Dahab,MohammedA.;Mahdy,HazemA.[BioorganicandMedicinalChemistry,2021,vol.46]

[13]Alanazi,MohammedM.;Mahdy,HazemA.;Alsaif,NawafA.;Obaidullah,AhmadJ.;Alkahtani,HamadM.;Al-Mehizia,AbdulrahmanA.;Alsubaie,SultanM.;Dahab,MohammedA.;Eissa,IbrahimH.[BioorganicChemistry,2021,vol.112]

[14]Alanazi,MohammedM.;Alanazi,WaelA.;Alasmari,AbdullahF.;Albassam,Hussam;Alsaif,NawafA.;Elwan,Alaa;Mahdy,HazemA.;Obaidullah,AhmadJ.;Taghour,MohammedS.[MolecularDiversity,2021]

[1]Liu,Xue-Kun;Ma,Long-Xu;Wei,Zhi-Yu;Cui,Xun;Zhan,Shi;Yin,Xiu-Mei;Piao,Hu-Ri[Molecules,2017,vol.22,#2]

[2]Ibrahim;Taghour;Metwaly;Belal;Mehany;Elhendawy;Radwan;Yassin;El-Deeb;Hafez;ElSohly;Eissa[EuropeanJournalofMedicinalChemistry,2018,vol.155,p.117-134]

[3]Eissa,IbrahimH.;Metwaly,AhmedM.;Belal,Amany;Mehany,AhmedB.M.;Ayyad,RezkR.;El-Adl,Khaled;Mahdy,HazemA.;Taghour,MohammedS.;El-Gamal,KamalM.A.;El-Sawah,MohamadE.;Elmetwally,SouadA.;Elhendawy,Mostafa.A.;Radwan,MohamedM.;ElSohly,MahmoudA.[ArchivderPharmazie,2019,vol.352,#11]

[4]El-Adl,Khaled;El-Helby,Abdel-GhanyA.;Sakr,Helmy;Elwan,Alaa[BioorganicChemistry,2020,vol.105]

[5]El-Adl,Khaled;El-Helby,Abdel-GhanyA.;Sakr,Helmy;Elwan,Alaa[NewJournalofChemistry,2021,vol.45,#2,p.881-897]

[6]Alsaif,NawafA.;Dahab,MohammedA.;Alanazi,MohammedM.;Obaidullah,AhmadJ.;Al-Mehizia,AbdulrahmanA.;Alanazi,ManalM.;Aldawas,Saleh;Mahdy,HazemA.;Elkady,Hazem[BioorganicChemistry,2021,vol.110]

[7]Alanazi,MohammedM.;Mahdy,HazemA.;Alsaif,NawafA.;Obaidullah,AhmadJ.;Alkahtani,HamadM.;Al-Mehizia,AbdulrahmanA.;Alsubaie,SultanM.;Dahab,MohammedA.;Eissa,IbrahimH.[BioorganicChemistry,2021,vol.112]

[8]Alsaif,NawafA.;Taghour,MohammedS.;Alanazi,MohammedM.;Obaidullah,AhmadJ.;Alanazi,WaelA.;Alasmari,Abdullah;Albassam,Hussam;Dahab,MohammedA.;Mahdy,HazemA.[BioorganicandMedicinalChemistry,2021,vol.46]

[9]Alanazi,MohammedM.;Alanazi,WaelA.;Alasmari,AbdullahF.;Albassam,Hussam;Alsaif,NawafA.;Elwan,Alaa;Mahdy,HazemA.;Obaidullah,AhmadJ.;Taghour,MohammedS.[MolecularDiversity,2021]

[10]Abdelgawad,MohamedA.;El-Adl,Khaled;El-Helby,Abdel-GhanyA.;El-Sherbiny,Mohamed;El-morsy,Ahmed;Elwan,Alaa;Ghoneim,MohammedM.;Sakr,Helmy[JournalofEnzymeInhibitionandMedicinalChemistry,2022,vol.37,#1,p.1556-1567]

[1]Liu,Xue-Kun;Ma,Long-Xu;Wei,Zhi-Yu;Cui,Xun;Zhan,Shi;Yin,Xiu-Mei;Piao,Hu-Ri[Molecules,2017,vol.22,#2]

62603-54-7    102391-98-0   
(4-(1,2,4-triazolo4,3-aquinoxalin-4-yl)piperazin-1-yl)(4-fluorophenyl)methanone 

[1]Molecules,2017,vol.22

62603-54-7    54042-47-6   
(4-(1,2,4-triazolo4,3-aquinoxalin-4-yl)piperazin-1-yl)(4-chlorophenyl)methanone 

[1]Molecules,2017,vol.22

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 62603-54-7
Tags:62603-54-7 Molecular Formula|62603-54-7 MDL|62603-54-7 SMILES|62603-54-7 4-Chloro[1,2,4]triazolo[4,3-a]quinoxaline